These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 7758173

  • 41. Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation.
    Edlin RS, Tsai S, Yamanouchi D, Wang C, Liu B, Kent KC.
    J Vasc Surg; 2009 May; 49(5):1289-95. PubMed ID: 19394554
    [Abstract] [Full Text] [Related]

  • 42. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans.
    Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD, Colombo A.
    Circulation; 2002 Nov 19; 106(21):2649-51. PubMed ID: 12438288
    [Abstract] [Full Text] [Related]

  • 43. A cascade model for restenosis. A special case of atherosclerosis progression.
    Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK.
    Circulation; 1992 Dec 19; 86(6 Suppl):III47-52. PubMed ID: 1424051
    [Abstract] [Full Text] [Related]

  • 44. Quantification of the cell-cycle inhibitors p27(Kip1) and p21(Cip1) in human atherectomy specimens: primary stenosis versus restenosis.
    Braun-Dullaeus RC, Ziegler A, Bohle RM, Bauer E, Hein S, Tillmanns H, Haberbosch W.
    J Lab Clin Med; 2003 Mar 19; 141(3):179-89. PubMed ID: 12624599
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries.
    Riessen R, Wight TN, Pastore C, Henley C, Isner JM.
    Circulation; 1996 Mar 15; 93(6):1141-7. PubMed ID: 8653834
    [Abstract] [Full Text] [Related]

  • 48. Comparison of proliferative activity in coronary plaques from patients with coronary ischemia. Histopathological and immunohistochemical analysis.
    Ueda H, Imazu M, Hayashi Y, Ono K, Yasui W, Yamakido M.
    Hiroshima J Med Sci; 1997 Mar 15; 46(1):31-42. PubMed ID: 9114565
    [Abstract] [Full Text] [Related]

  • 49. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture.
    Bennett MR.
    Cardiovasc Res; 1999 Feb 15; 41(2):361-8. PubMed ID: 10341835
    [Abstract] [Full Text] [Related]

  • 50. Frequency and consequences of intimal hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses.
    Miller MJ, Kuntz RE, Friedrich SP, Leidig GA, Fishman RF, Schnitt SJ, Baim DS, Safian RD.
    Am J Cardiol; 1993 Mar 15; 71(8):652-8. PubMed ID: 8447260
    [Abstract] [Full Text] [Related]

  • 51. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation.
    Yoneda S, Abe S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T.
    Coron Artery Dis; 2013 Aug 15; 24(5):368-73. PubMed ID: 23744617
    [Abstract] [Full Text] [Related]

  • 52. Use of human tissue specimens obtained by directional atherectomy to study restenosis.
    Isner JM, Kearney M, Bauters C, Leclerc G, Nikol S, Pickering JG, Riessen R, Weir L.
    Trends Cardiovasc Med; 1994 Aug 15; 4(5):213-21. PubMed ID: 21244870
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity.
    Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ.
    Atherosclerosis; 1995 Jul 15; 116(1):43-57. PubMed ID: 7488332
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis.
    Krishnan P, Purushothaman KR, Purushothaman M, Turnbull IC, Tarricone A, Vasquez M, Jain S, Baber U, Lascano RA, Kini AS, Sharma SK, Moreno PR.
    Atherosclerosis; 2016 Aug 15; 251():226-233. PubMed ID: 27399649
    [Abstract] [Full Text] [Related]

  • 57. [Pathophysiology and pathobiochemistry of restenosis].
    Höfling B, Gonschior P, Nikol S, Bauriedel G, Welsch U, Nerlich A.
    Z Kardiol; 1994 May 15; 83(5):313-8. PubMed ID: 8053238
    [Abstract] [Full Text] [Related]

  • 58. Expression of tumour necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy.
    Clausell N, de Lima VC, Molossi S, Liu P, Turley E, Gotlieb AI, Adelman AG, Rabinovitch M.
    Br Heart J; 1995 Jun 15; 73(6):534-9. PubMed ID: 7626352
    [Abstract] [Full Text] [Related]

  • 59. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents.
    Chieffo A, Foglieni C, Nodari RL, Briguori C, Sangiorgi G, Latib A, Montorfano M, Airoldi F, Michev I, Carlino M, Colombo A, Maseri A.
    Am J Cardiol; 2009 Dec 15; 104(12):1660-7. PubMed ID: 19962471
    [Abstract] [Full Text] [Related]

  • 60. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.
    Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE.
    N Engl J Med; 1996 Aug 29; 335(9):624-30. PubMed ID: 8687516
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.